Abstract
Abstract. Comparative assessment of effectiveness showed that integration of immunological data significantly increases the accuracy of prognosis and compensates for the shortcomings of traditional scales. Thus, as a result of the study, we achieved the main goal of the study - improved prediction of the outcomes of complex treatment of cancer of the oral mucosa by developing a pathogenetically substantiated method based on changes in immune parameters.
References
1. Sung H., Ferlay J., Siegel R. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries // CA: A Cancer Journal for Clinicians. – 2021. – Vol. 71, No. 3. – P. 209–249.
2. Кочурова Е. В., Муханов А. А. Местные осложнения при лучевом и химиотерапевтическом лечении пациентов с плоскоклеточным раком слизистой оболочки полости рта // Вопросы онкологии. – 2018. – Т. 64, № 2. – С. 166–170.
3. Романов И. С., Гельфанд И. М., Удинцов Д. Б. Тактика лечения ранних стадий рака слизистой оболочки полости рта // Head and Neck / Голова и шея. Российское издание. – 2016. – № 3. – С. 44
4. National Comprehensive Cancer Network (NCCN). Clinical Practice Guidelines in Oncology: Head and Neck Cancers. – Version 2.2024. – 185 p.

This work is licensed under a Creative Commons Attribution 4.0 International License.